Pfizer pouring COVID profits into cancer battle, CEO Bourla says
By Michael Erman (Reuters) – Pfizer Inc is pouring the windfall profits from its COVID-19 vaccine and treatment into developing products to battle cancer, most notably in its $43 billion purchase of Seagen Inc, Chief Executive Albert Bourla said at a Reuters newsmaker event on Thursday. “Pfizer is giving all the profits that we made from COVID in ’21 and ’22 and what we will make in ’23 to acquire […]